Early Phase Cancer Immunotherapy

Early Phase Cancer Immunotherapy

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Patel, Sandip Pravin (Editor, http://id.loc.gov/vocabulary/relators/edt), Kurzrock, Razelle (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2018.
Edition:1st ed. 2018.
Series:Current Cancer Research,
Subjects:
Cancer research.
Cancer Research.
Online Access:Full Text via HEAL-Link
Description
Summary:This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Physical Description:XI, 331 p. 24 illus., 15 illus. in color. online resource.
ISBN:9783319637570
ISSN:2199-2584
DOI:10.1007/978-3-319-63757-0

Similar Items